Clinical trial
The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity
Opening soon · Not applicable · 1 countries · Registry ID NCT07542327
Opening soonNot applicableObservational
What this study is about
The purpose of this study is to explore if GPCR-autoantibodies: 1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 60 Years
SexAll
Healthy volunteersNot accepted
ConditionObesity, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus, Obesity and Obesity-related Medical Conditions
Full registry criteria
Inclusion Criteria: * Inhabitant in the Region of Southern Denmark * BMI above 30kg/m2 * age between 18 and 60 years. Exclusion Criteria: * individuals previously treated with GLP-1RA medication for any indication * Individuals who have previously undergone bariatric surgery * Individuals with type 1 diabetes
Treatments and study arms
The registry does not list a named intervention.
Primary outcomes
Exploring the pressence and role of GPCR-autoantibodies in obesityAt the time of enrolement
explore the pressence of GPCR-autoantibodies in people living with obesity, and if there is any association with the degree of obesity
Study locations
1 locations were listed when this page was built. The first 40 are shown.
University Hospital of Southern Denmark, Esbjerg🇩🇰 Esbjerg, Region Syddanmark, Denmark
Anitta Ø Johansen, Chief consultantContact
Claus B Juhl, Professor, MD, PhDPrincipal Investigator
Tobias M Windedal, MDSub Investigator